Position in SPRY
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$33,032,344
-$8,395,626 QoQ
Shares Held
4,113,617
+15.7% QoQ
Ownership
4.14%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. SPRY ranks #18 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | IMUX |
Immunic, Inc.
|
8,243,941 | $91,507,745 | |
| 4 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 5 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 6 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 |
All Filings in SPRY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,032,344 | 4,113,617 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $41,427,970 | 3,556,049 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $31,125,071 | 3,097,022 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $26,219,933 | 1,502,575 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $12,613,450 | 1,002,659 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||